Marchés français ouverture 2 h 49 min
  • Dow Jones

    31 391,52
    -143,99 (-0,46 %)
  • Nasdaq

    13 358,79
    -230,04 (-1,69 %)
  • Nikkei 225

    29 477,27
    +69,10 (+0,23 %)

    +0,0006 (+0,05 %)

    29 587,74
    +491,88 (+1,69 %)

    40 660,42
    -264,73 (-0,65 %)
  • CMC Crypto 200

    +0,08 (+0,01 %)
  • S&P 500

    3 870,29
    -31,53 (-0,81 %)

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type, By Service And Segment Forecasts, 2021 - 2028

·3 min de lecture

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, Clinical), By Service (Clinical Monitoring, Regulatory/Medical Affairs), And Segment Forecasts, 2021 - 2028

New York, Feb. 18, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type, By Service And Segment Forecasts, 2021 - 2028" -

Healthcare CRO Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 66.1 billion by 2028. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The increasing cost of drug development is expected to drive the market over the forecast period. Moreover, rising clinical trial cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations (CROs). Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

However, the CRO market has been significantly impacted by the ongoing pandemic.The worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of other vaccines and drugs.

At the peak of the pandemic, vaccines and treatments for COVID-19 accounted for 30% of all the trials in the U.S. This resulted in other trials being put on hold.

The CRO market is recovering slowly through a hybrid approach.They are playing a significant role in helping sponsors and sites to start clinical trials.

Market players have already built powerful tools to support virtual clinical trials. They are ready to rapidly assist sponsors to shift to this new environment and leverage the available tools.

Healthcare CRO Market Report Highlights
• Based on type, clinical trial services dominated the global market in 2020 and held a share of 76.7% owing to the fact that it comprises four elaborate phases, including human subjects
• By service, the clinical monitoring segment held the largest revenue share in 2020
• North America held a significant share in 2020 due to the presence of several global players, who invest a major part of their revenue in research activities
• Asia Pacific is anticipated to register the fastest CAGR over the forecast period due to the reduced cost it offers in comparison to the U.S. and other developed economies. China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001